US FDA approves full Pfizer vaccine The private sector can purchase by themselves without having to wait for the state.

US FDA approves full use of Pfizer vaccine This will allow private agencies to directly procure vaccines. No need to buy through government agencies.

The US Food and Drug Administration (FDA) has fully approved the use of a two-dose vaccine against the coronavirus developed by Pfizer and Biotech, according to the BBC. (full approval) for general use in people aged 16 years or over Originally, it was only used in an emergency.

Pfizer/Biontech Vaccines It is the first vaccine to be fully approved in the US after the FDA reviewed the data. Including production and data from about 44,000 vaccinated people, this vaccine is 91% effective against COVID-19. It is safe. and standardized production

As a result of the FDA's full approval, now private hospitals, private agencies Universities and companies Pfizer/Biontech vaccines can now be purchased directly. It is not necessary to purchase through a government agency. While the vaccine is used in children aged 12-15 years, it is still an emergency use.

The FDA has been under heavy pressure before. to speed up the approval process for the use of vaccines against COVID-19 in full for employers or organizations Able to provide vaccines to their employees after the United States faces lower vaccination rates. because the people are still hesitant But the outbreak of the delta virus This has caused the injection rate to increase somewhat in the past few weeks.

The FDA hopes that the approval of the Pfizer/Biotech vaccine will boost people's confidence in getting the vaccine. An opinion poll by the Kaiser Family Foundation released at the end of June indicated that About 30% of unvaccinated Americans will be vaccinated if fully approved by the FDA.